Unraveling the genetics of cancer: Genome sequencing and beyond

Kit Man Wong, Thomas J. Hudson, John Douglas Mcpherson

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Advances in next-generation sequencing technology are enabling the systematic analyses of whole cancer genomes, providing insights into the landscape of somatic mutations and the great genetic heterogeneity that defines the unique signature of an individual tumor. Moreover, integrated studies of the genome, epigenome, and transcriptome reveal mechanisms of tumorigenesis at multiple levels. Progress in sequencing technologies and bioinformatics will improve the costs, sensitivity, and accuracy of detecting somatic mutations, while large-scale projects are underway to coordinate cancer genome sequencing at the global level to facilitate the generation and dissemination of high-quality uniform genetic data. These developments will create opportunities for deeper studies of cancer genetics and the clinical application of genome sequencing, and will motivate further research in cancer pathogenesis.

Original languageEnglish (US)
Pages (from-to)407-430
Number of pages24
JournalAnnual Review of Genomics and Human Genetics
Volume12
DOIs
StatePublished - Jul 13 2011
Externally publishedYes

Fingerprint

Genome
Neoplasms
Technology
Mutation
Genetic Heterogeneity
Computational Biology
Transcriptome
Carcinogenesis
Costs and Cost Analysis
Research

Keywords

  • Bioinformatics
  • Epigenome
  • Next-generation sequencing
  • Somatic mutation
  • Transcriptome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Molecular Biology

Cite this

Unraveling the genetics of cancer : Genome sequencing and beyond. / Wong, Kit Man; Hudson, Thomas J.; Mcpherson, John Douglas.

In: Annual Review of Genomics and Human Genetics, Vol. 12, 13.07.2011, p. 407-430.

Research output: Contribution to journalArticle

@article{10d03ed133d94f269fef63ff10779834,
title = "Unraveling the genetics of cancer: Genome sequencing and beyond",
abstract = "Advances in next-generation sequencing technology are enabling the systematic analyses of whole cancer genomes, providing insights into the landscape of somatic mutations and the great genetic heterogeneity that defines the unique signature of an individual tumor. Moreover, integrated studies of the genome, epigenome, and transcriptome reveal mechanisms of tumorigenesis at multiple levels. Progress in sequencing technologies and bioinformatics will improve the costs, sensitivity, and accuracy of detecting somatic mutations, while large-scale projects are underway to coordinate cancer genome sequencing at the global level to facilitate the generation and dissemination of high-quality uniform genetic data. These developments will create opportunities for deeper studies of cancer genetics and the clinical application of genome sequencing, and will motivate further research in cancer pathogenesis.",
keywords = "Bioinformatics, Epigenome, Next-generation sequencing, Somatic mutation, Transcriptome",
author = "Wong, {Kit Man} and Hudson, {Thomas J.} and Mcpherson, {John Douglas}",
year = "2011",
month = "7",
day = "13",
doi = "10.1146/annurev-genom-082509-141532",
language = "English (US)",
volume = "12",
pages = "407--430",
journal = "Annual Review of Genomics and Human Genetics",
issn = "1527-8204",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Unraveling the genetics of cancer

T2 - Genome sequencing and beyond

AU - Wong, Kit Man

AU - Hudson, Thomas J.

AU - Mcpherson, John Douglas

PY - 2011/7/13

Y1 - 2011/7/13

N2 - Advances in next-generation sequencing technology are enabling the systematic analyses of whole cancer genomes, providing insights into the landscape of somatic mutations and the great genetic heterogeneity that defines the unique signature of an individual tumor. Moreover, integrated studies of the genome, epigenome, and transcriptome reveal mechanisms of tumorigenesis at multiple levels. Progress in sequencing technologies and bioinformatics will improve the costs, sensitivity, and accuracy of detecting somatic mutations, while large-scale projects are underway to coordinate cancer genome sequencing at the global level to facilitate the generation and dissemination of high-quality uniform genetic data. These developments will create opportunities for deeper studies of cancer genetics and the clinical application of genome sequencing, and will motivate further research in cancer pathogenesis.

AB - Advances in next-generation sequencing technology are enabling the systematic analyses of whole cancer genomes, providing insights into the landscape of somatic mutations and the great genetic heterogeneity that defines the unique signature of an individual tumor. Moreover, integrated studies of the genome, epigenome, and transcriptome reveal mechanisms of tumorigenesis at multiple levels. Progress in sequencing technologies and bioinformatics will improve the costs, sensitivity, and accuracy of detecting somatic mutations, while large-scale projects are underway to coordinate cancer genome sequencing at the global level to facilitate the generation and dissemination of high-quality uniform genetic data. These developments will create opportunities for deeper studies of cancer genetics and the clinical application of genome sequencing, and will motivate further research in cancer pathogenesis.

KW - Bioinformatics

KW - Epigenome

KW - Next-generation sequencing

KW - Somatic mutation

KW - Transcriptome

UR - http://www.scopus.com/inward/record.url?scp=80052765035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052765035&partnerID=8YFLogxK

U2 - 10.1146/annurev-genom-082509-141532

DO - 10.1146/annurev-genom-082509-141532

M3 - Article

C2 - 21639794

AN - SCOPUS:80052765035

VL - 12

SP - 407

EP - 430

JO - Annual Review of Genomics and Human Genetics

JF - Annual Review of Genomics and Human Genetics

SN - 1527-8204

ER -